JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Gilead Sciences (NASDAQ:GILD) Stock
Gilead Sciences (NASDAQ:GILD – Get Free Report) had its price target lifted by stock analysts at JPMorgan Chase & Co. from ...
Citi “Very Bullish” on Gilead’s (NASDAQ:GILD) HIV Business
Citigroup said it’s “very bullish” on Gilead’s HIV franchise, arguing it’s the drugmaker’s biggest value driver as the company’s new ...
Gilead Sciences Inc. stock outperforms competitors on strong trading day
Gilead Sciences Inc. closed 10.06% short of its 52-week high of $119.96, which the company achieved on March 10th.
Yahoo Finance4d
Gilead Sciences (GILD) Stock Drops Despite Market Gains: Important Facts to Note
In the latest trading session, Gilead Sciences (GILD) closed at $106.67, marking a -0.38% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 1.77% for the day.
If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today
Buying $100 In GILD: If an investor had bought $100 of GILD stock 20 years ago, it would be worth $1,262.82 today based on a ...
A Closer Look at Gilead Sciences's Options Market Dynamics
Investors with a lot of money to spend have taken a bearish stance on Gilead Sciences GILD. And retail traders should know.
Citi remains ‘very bullish’ on Gilead HIV franchise
HIV franchise remains its biggest value driver. The firm believes a strong launch of lenacapavir in pre-exposure ...
Yahoo Finance4d
Gilead Sciences (GILD) Stock Drops Despite Market Gains: Important Facts to Note
In the latest trading session, Gilead Sciences (GILD) closed at $106.67, marking a -0.38% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 1.77% for the day.